Research shows that the number of people who develop allergic diseases is rising. Today, 30–35 percent of people will develop allergies at some point in their lives. Factors like hormones, stress, ...

Apr. 10, 2024 — One of the molecules responsible for triggering the inflammation that causes allergic respiratory diseases, such as asthma and allergic rhinitis, has ... Feb. 29, 2024 ...

Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological ...

One of the molecules responsible for triggering the inflammation that causes allergic respiratory diseases, such as asthma and allergic rhinitis, has just been discovered by scientists from the ...

Mahomies Foundation and FARE are partnering to form 15 and FARE and bring the FARE Neighborhoods Initiative and FARE’s Food Allergy Academy training to Kansas City.

Allergic disease is one of Australia's greatest public health challenges, with one in 10 developing a food allergy in their ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

The program is jointly sponsored by the departments of Internal Medicine and Pediatrics, and administered by the Section of Allergy and Immunology, Division of Infectious Diseases, Allergy and ...

There are studies that show a protective effect, no effect or even a predisposing effect of using probiotics and/or prebiotics in preventing allergic disease. A variety of methodological issues ...

The Division of Infectious Diseases, Allergy and Immunology provides clinical instruction, consultation and other related services for SSM Health Saint Louis University Hospital and the VA Saint Louis ...

Following is a transcript of the video. I'm Peter Green. I'm the director of the Celiac Disease Center at Columbia University. Celiac disease is actually a disease of Caucasians. The genes that ...

The data shows that when administered sublingually via a dissolvable tablet in a lung model of allergic disease, ‘1104 achieves comparable positive results across multiple inflammatory immune ...